Acadian Asset Management LLC lifted its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 3,192.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,762 shares of the company's stock after purchasing an additional 5,587 shares during the quarter. Acadian Asset Management LLC's holdings in Molina Healthcare were worth $1,897,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the business. Rothschild Investment LLC lifted its position in Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares during the period. Zions Bancorporation National Association UT acquired a new stake in Molina Healthcare during the 1st quarter worth about $29,000. Deseret Mutual Benefit Administrators lifted its position in Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares during the period. Elequin Capital LP lifted its position in Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after acquiring an additional 58 shares during the period. Finally, Silver Oak Securities Incorporated acquired a new stake in Molina Healthcare during the 1st quarter worth about $34,000. Institutional investors and hedge funds own 98.50% of the company's stock.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO James Woys acquired 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the purchase, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.26% of the stock is currently owned by insiders.
Molina Healthcare Price Performance
Shares of Molina Healthcare stock opened at $176.47 on Wednesday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a twelve month low of $151.95 and a twelve month high of $361.80. The business has a 50-day moving average price of $177.21 and a 200 day moving average price of $264.38. The firm has a market cap of $9.56 billion, a PE ratio of 8.70 and a beta of 0.54.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. During the same quarter in the prior year, the firm earned $5.86 EPS. Molina Healthcare's revenue for the quarter was up 15.7% on a year-over-year basis. Sell-side analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have commented on MOH. JPMorgan Chase & Co. lowered their price target on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research report on Tuesday, July 29th. Truist Financial reaffirmed a "hold" rating and set a $180.00 price target (down previously from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Sanford C. Bernstein lowered their price target on Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a research report on Friday, September 5th. Morgan Stanley cut Molina Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $364.00 to $266.00 in a report on Thursday, July 10th. Finally, UBS Group lowered their target price on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Three analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and an average price target of $225.18.
Check Out Our Latest Report on MOH
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.